Viamet Pharmaceuticals (Bermuda), Ltd.
Records under this name other than patents Viamet Pharmaceuticals (Bermuda), Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Viamet Pharmaceuticals (Bermuda), Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,085,984 | Metalloenzyme Inhibitor Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 10,538,511 | Metalloenzyme Inhibitor Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 11,040,034 | Metalloenzyme Inhibitor Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 11,136,309 | Metalloenzyme Inhibitor Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 11,919,883 | Metalloenzyme Inhibitor Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 12,458,642 | Metalloenzyme Inhibitor Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 10,357,493 | Metalloenzyme inhibitor compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,370,194 | Metalloenzyme inhibitor compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,938,134 | Metalloenzyme inhibitor compounds Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,680,270 | Metallo-oxidoreductase inhibitors using metal binding moieties in combination with targeting moieties Formerly held Lapsed on the fee record Ended Mar 25, 2022 · USPTO record | Lapsed on the fee record | Ended Mar 25, 2022 | USPTO record |